TScan Therapeutics Inc.

05/09/2024 | Press release | Distributed by Public on 05/09/2024 05:00

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors